We studied the ELSA-pS2'#{176} immunoradiometric kit (CIS Bio International) for pS2 protein assay in breast cancer cytosols according to classic validation methods. In addition, we studied correlations between pS2, steroid receptors, and cathepsin-D assays. Repeatability (CV = 1.5% to 4.8%) and reproducibility (CV = 1.6% to 4.9%) were good. The results were linearly related to pS2 concentrations between 205 and 2200 ng/L; the detection limit was 40 ng/L. The accuracy of the assay was measured by assessing recovery; analytical recoveries were near 100% throughout the standard curve. The use of different compounds for cytosol preparation (Tns 10 mmol/L or phosphate 25 mmol/L, KCI 0.4 mol/L, bovine serum albumin 1 gIL) had no effect on p52 results. pS2 was assayed in breast tumor cytosols from 197 postmenopausal and 92 premenopausal patients. The mean value was 24 zg/g of protein; the median and 25th and 75th percentiles were 6, 1, and 23 pg/g protein, respectively. We observed a relation between concentrations of pS2 and those of estrogen and progesterone receptors, but there was no relationship between the concentrations of pS2 and cathepsin-D.
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pS2 protein is a 60-amino acid polypeptide (7000 Da) (1), the synthesis of which is regulated by estrogens in human breast cancer (2). The pS2 gene has been isolated and cloned, and gene products have been studied previously (3,4). pS2 protein is a marker of good prognosis and of responsiveness to hormone therapy in breast cancer patients, and may determine a subgroup of patients who might benefit from an adjuvant therapy (5) . Here we present a technical evaluation of the immunoassay of p82 in breast cancer cytosols (ELSAp82tm; CIS Bio International, Gif Sur Yvette, France).
MaterIals and Methods Reagents
The assay is based on an immunoradiometric two-site assay with a solid phase. pS2 protein is bound between two monoclonal antibodies directed against different epitopes. The first antibody (BC6) is coated on the ELSA solid phase (coated tube), whereas the second (BC4) is 1251-labeled and used as a tracer. The total activity of the kit is <370 kBq (10 pCi). p82 standards contain highly purified pS2 protein 
pS2 Stability
The stability of the pS2 protein was observed by studying the resistance of the molecule to freezing and In this study, we pulverized 17 breast cancer samples in liquid nitrogen, separated them into two aliquots, and homogenized them in either Tris or phosphate buffer. The regression curve obtained between Ti-is results (B) and phosphate results (A) was B = 1.12A -3 ng/L (r = 0.999), and results by both methods for contents ranging from 0 to 284 ng/L were very similar.
The effect of KC1 (0.4 moIIL) and of BSA (1 gIL) was studied with 10 breast cancer cytosols. Identical results were obtained in the presence or absence of either KC1 or BSA, and showed that this pS2 assay was unaffected by different medium conditions.
pS2 Concentrations in Breast Cancer
The mean pS2 concentration in 289 cytosols from breast cancer patients was 24 p.g/g of protein, the median was 6 4tg/g of protein, and the 25th and 75th percentiles were 1 and 23 .tg/g of protein, respectively. The distribution of values is presented in Figure 2 . As shown in Figure 3 positive. In tumors containing both ER and PR, 75% to 79% of tumors were p82 positive.
DIscussion
In this technical evaluation of the ELSA-pS2 kit, we found the kit easy to handle. The within-run and between-nm precisions were always <5%. Recovery tests were good, even beyond the standard range (200-2200 ng/L). Given the variety of cytosol preparation techniques, it was important to show that these techniques would not influence the assay (possible bias for multicenter studies). The composition of buffer, total protein concentrations, or presence of KCI seem not to interfere with the p82 results. The pS2 protein concentration is not influenced by freezing and thawing. There is a lack of correlation between cathepsin-D and p82, for which the prognostic values are opposite (high concentrations of cathepsin-D correspond to a poor prognosis).
The estrogen-induced characteristics of pS2 are confirmed by the strong relation between steroid receptors (ER and PR) and p82 concentrations, but further studies are necessary to assess more precisely the cutoff value of pS2 that best predicts hormone responsiveness.
